China approves vaccines for XBB variant: Zhong Nanshan

China has approved two Covid-19 vaccines to counter the country’s currently dominant XBB variant and the new vaccines will soon be released to the market, China’s top respiratory disease expert Zhong Nanshan revealed yesterday. According to Zhong, a small wave of infections at the end of April and early May was “anticipated,” and the XBB mutant has become a mainstream strain of Covid-19 in China. According to the data disclosed by the China Center for Disease Control and Prevention (China CDC), the infection rate of the XBB mutation increased from 0.2% in mid-February to 74.4% in late April and then to 83.6% in early May.